Clinical Trial Update: Characterization of the Pharmacokinetics of Oral Selenium Compounds in Humans Before and Following Supplementation

View source ↗

Summary

A completed clinical trial characterizes the pharmacokinetics of oral selenium compounds in humans before and after supplementation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Selenium (oral supplement) (selenium)
• Selenomethionine (selenomethionine)
• Sodium selenite (sodium selenite)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cancer | Status: COMPLETED